Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2026-01-18 @ 3:24 PM
Study NCT ID:
NCT05220267
Status:
UNKNOWN
Last Update Posted:
2022-02-02
First Post:
2021-12-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma
Sponsor:
Sun Yat-sen University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Clear Cell Renal Carcinoma | View |
Keywords: